Chinese patent medicine for treating sequelae of cerebral infarction and preparation method thereof

Abstract

The invention belongs to the field of medicines and in particular relates to a Chinese patent medicine for treating sequelae of cerebral infarction, which can basically promote the recovery of the nerve functions of patients suffering from cerebral apoplexy hemiplegia, improve the living conditions of the patients and increase the living ability of the patients by taking multiple traditional Chinese medicinal materials as raw materials, as well as a preparation method thereof. The Chinese patent medicine is prepared from the following raw materials in parts by weight: 10-15 parts of prepared rehmannia root, 8-12 parts of morinda root, 10-15 parts of chuanxiong rhizome, 10-15 parts of leech, 4-10 parts of rhubarb, 8-12 parts of astragalus root, 8-12 parts of rhizoma acori graminei, 2-5 parts of borneol and 10-15 parts of talcum powder. The Chinese patent medicine is stable in medicine effect and directly acts on a focus through blood and blood vessels simultaneously to improve damaged brain cells and protect undamaged cells to create a favorable intracerebral environment, thereby achieving the effects of preventing thrombosis again and preventing the blood vessels from being clogged again by atheromatous plaque.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a Chinese patent medicine which can effectively treat sequelae of cerebral infarction by using various Chinese medicinal materials as raw materials and a preparation method thereof. Background technique [0002] The sequelae of cerebral infarction generally refer to the sequelae of stroke. Stroke is the name of a disease in traditional Chinese medicine, and it is also the collective and common name for acute cerebrovascular diseases. This disease is a group of diseases whose main clinical manifestations are cerebral ischemia and hemorrhagic injury. Also known as stroke or cerebrovascular accident, it has a very high mortality rate and disability rate, and is mainly divided into hemorrhagic stroke (cerebral hemorrhage or subarachnoid hemorrhage) and ischemic stroke (cerebral infarction, cerebral thrombosis ) two categories. The early mortality rate of hemorrhagic stroke is ver...

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to solve the problems of existing Western medicine in the treatment of cerebral apoplexy sequelae, such as single target, easy to cause drug resistance, obvious side effects, and high relapse caused by traditional rehabilitation therapy. A Chinese patent medicine for treating sequelae of cerebral infarction without side effects and its preparation method